|
English
|
正體中文
|
简体中文
|
總筆數 :2851802
|
|
造訪人次 :
44720694
線上人數 :
906
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
顯示項目 884541-884550 / 2343346 (共234335頁)
<< < 88450 88451 88452 88453 88454 88455 88456 88457 88458 88459 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2021-03-11T08:29:29Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; JEN-CHANG KO; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-05-02T03:49:12Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; Ko J.-C.; JIN-YUAN SHIH; Yu C.-J. |
| 臺大學術典藏 |
2021-05-02T04:37:07Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; JANN-YUAN WANG; Ko J.-C.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-11-29T05:55:31Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Liang, Sheng-Kai; Keng, Li-Ta; Chang, Chia-Hao; Wen, Yueh-Feng; Lee, Meng-Rui; CHING-YAO YANG; Wang, Jann-Yuan; Ko, Jen-Chung; Shih, Jin-Yuan; Yu, Chong-Jen |
| 臺大學術典藏 |
2021-05-02T03:29:21Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; Ko J.-C.; Shih J.-Y.; CHONG-JEN YU |
| 臺大學術典藏 |
2021-02-08T08:05:08Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Jen-Chung Ko;Sheng-Kai Liang;Li-Ta Keng;Chia-Hao Chang;Yueh-Feng Wen ; Meng-Rui Lee ; Ching-Yao Yang ; Jann-Yuan Wang ; Jin-Yuan Shih ; Chong-Jen Yu; JEN-CHUNG KO; SHENG-KAI LIANG; LI-TA KENG; CHIA-HAO CHANG; Yueh-Feng Wen ; Meng-Rui Lee ; Ching-Yao Yang ; Jann-Yuan Wang ; Jin-Yuan Shih ; Chong-Jen Yu |
| 臺大學術典藏 |
2022-06-27T06:59:38Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; Ko J.-C.; Shih J.-Y.; CHONG-JEN YU |
| 國立臺灣大學 |
2004 |
Treatment Outcome and Pattern of Failure in 77 Patients with Sinonasal Natural Killer/T-Cell or T-Cell Lymphoma
|
李啟誠; 田蕙芬; 唐季祿; 姚明; 陳耀昌; 蘇益仁; 許世明; 洪瑞隆; LI, CHI-CHENG; TIEN, HWEI-FANG; TANG, JIH-LUH; YAO, MING; CHEN, YAO-CHANG; SU, IH-JEN; HSU, SU-MING; HONG, RUEY-LONG |
| 臺大學術典藏 |
2021-05-26T09:08:15Z |
Treatment Outcome and Pattern of Failure in 77 Patients with Sinonasal Natural Killer/T-Cell or T-Cell Lymphoma
|
Li C.-C.; Tien H.-F.; Tang J.-L.; Yao M.; YAO-CHANG CHEN; Su I.-J.; Hsu S.-M.; Hong R.-L. |
| 臺大學術典藏 |
2021-03-09T06:46:13Z |
Treatment Outcome and Pattern of Failure in 77 Patients with Sinonasal Natural Killer/T-Cell or T-Cell Lymphoma
|
Li C.-C.;Tien H.-F.;Tang J.-L.;Yao M.;Chen Y.-C.;Su I.-J.;Hsu S.-M.;Ruey-Long Hong; Li C.-C.; Tien H.-F.; Tang J.-L.; Yao M.; Chen Y.-C.; Su I.-J.; Hsu S.-M.; RUEY-LONG HONG |
顯示項目 884541-884550 / 2343346 (共234335頁)
<< < 88450 88451 88452 88453 88454 88455 88456 88457 88458 88459 > >>
每頁顯示[10|25|50]項目
|
